White Paper
Efficacy of L-92™ in adult patients with atopic dermatitis
![Efficacy of L-92™ in adult patients with atopic dermatitis](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/8/8/2/3/3623288-6-eng-GB/Maypro-CS-Food-2016-Efficacy-of-L-92-in-adult-patients-with-atopic-dermatitis.png)
A 6 month double-blind, placebo-controlled study on 50 subjects revealed that L-92™, a heat-killed strain of L. acidophilus, effectively improves the symptoms and quality of life of patients with Th2 dominant skin inflammation, both during the study period and after. The study suggested L-92™ activates regulatory T cells, and Th1 cells.